Medicine
Cefazolin 3 g/50 mL injection
Cefazolin 3 g/50 mL injection is a generic prescription medicine for intravenous use, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Do not freeze. Store the unactivated unit at 20-25°C (68-77°F). Excursions…
Key facts
- Active ingredient (INN)
- Cefazolin
- Brand
- Sold under the generic name
- Strength
- 3 g/50 mL
- Dosage form
- Injection
- Route
- Intravenous
- Packs
- 24 containers of 50 mL
- Manufacturer
- B. Braun Medical
- Origin register
- US FDA, United States
- Storage
- Do not freeze. Store the unactivated unit at 20-25°C (68-77°F). Excursions permitted to 15-30°C (59-86°F). As with other cephalosporins, reconstituted Cefazolin for Injection USP and Dextrose Injection USP tends to darken depending on storage conditions, within the stated recommendations.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- J01DB04 Cefazolin
- HS code (indicative)
- 3004.20Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 10 March 2025
- Identifiers
- RxCUI 1665050, 1665060, 2630753DailyMed set ID 17f8f038-c204-4dab-80d7-6f7ac41ddbecNDC 0264-3107Application NDA050779
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 24 container in 1 case / 50 mL in 1 container | 0264-3107-11 | B. Braun Medical | 10 March 2025 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 4 October 1973 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Cefazolin
Clinical summary
Cefazolin is a cephalosporin antibacterial indicated for treatment of infections caused by susceptible isolates of the designated microorganisms in adult and pediatric patients for whom appropriate dosing with this formulation can be achieved, among other approved uses. MedsAcross supplies Cefazolin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about CefazolinFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Cefazolin Sodium prescribing information (B. Braun Medical) · U.S. National Library of Medicine, DailyMed
Need Cefazolin 3 g/50 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.